Clinical Trial Update: IQP-PO-101 for the Regulation of Bowel Movement Frequency [Phase 3]

View source ↗

Summary

Phase 3 trial update for IQP-PO-101 to regulate bowel movement frequency in constipation indicates the study status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• IQP-PO-101

Snippet

Sponsor: InQpharm Group | Conditions: Constipation, Irregular Bowel Movement Frequency | Phase 3 | Status: COMPLETED